The transcription factor T-bet regulates parasitemia and promotes pathogenesis during plasmodium berghei ANKA murine malaria

Journal of Immunology

Volumn 191, Issue 9, 2013, Pages 4699-4708

  Oakley, Miranda S ^a   Sahu, Bikash R ^a   Lotspeich Cole, Leda ^a   Solanki, Nehal R ^a   Majam, Victoria ^a   Pham, Phuong Thao ^a   Banerjee, Rajdeep ^a   Kozakai, Yukiko ^a   Derrick, Steven C ^a   Kumar, Sanjai ^a   Morris, Sheldon L ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; DIPEPTIDYL PEPTIDASE IV; EOTAXIN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; HERMES ANTIGEN; INTERFERON ALPHA BETA RECEPTOR 1; INTERFERON RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 17; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN ROR GAMMAT; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG; CCL2 PROTEIN, MOUSE; GATA3 PROTEIN, MOUSE; T BOX TRANSCRIPTION FACTOR; T-BOX TRANSCRIPTION FACTOR TBX21;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN MALARIA; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE PREDISPOSITION; FEMALE; HOST PARASITE INTERACTION; HOST RESISTANCE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PARASITE LOAD; PARASITEMIA; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RODENT MALARIA; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL; UPREGULATION; ANIMAL; BIOSYNTHESIS; BRAIN; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; DEFICIENCY; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; MALARIA; METABOLISM; PARASITOLOGY; PATHOGENICITY; PLASMODIUM BERGHEI;

ANIMALS; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CHEMOKINE CCL11; CHEMOKINE CCL2; FEMALE; GATA3 TRANSCRIPTION FACTOR; GRANULOCYTE COLONY-STIMULATING FACTOR; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PARASITEMIA; PLASMODIUM BERGHEI; T-BOX DOMAIN PROTEINS;

EID: 84886017430     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300396     Document Type: Article

References (62)

1. Finley, R. W., L. J. Mackey, and P. H. Lambert. 1982. Virulent P. berghei malaria: prolonged survival and decreased cerebral pathology in cell-dependent nude mice. J. Immunol. 129: 2213-2218.
2. Rénia, L., S. M. Potter, M. Mauduit, D. S. Rosa, M. Kayibanda, J. C. Deschemin, G. Snounou, and A. C. Grüner. 2006. Pathogenic T cells in cerebral malaria. Int. J. Parasitol. 36: 547-554.
3. Belnoue, E., M. Kayibanda, A. M. Vigario, J. C. Deschemin, N. van Rooijen, M. Viguier, G. Snounou, and L. Rénia. 2002. On the pathogenic role of brainsequestered alphabeta CD8+ T cells in experimental cerebral malaria. J. Immunol. 169: 6369-6375.
4. Nitcheu, J., O. Bonduelle, C. Combadiere, M. Tefit, D. Seilhean, D. Mazier, and B. Combadiere. 2003. Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. J. Immunol. 170: 2221-2228.
5. Potter, S., T. Chan-Ling, H. J. Ball, H. Mansour, A. Mitchell, L. Maluish, and N. H. Hunt. 2006. Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria. Int. J. Parasitol. 36: 485-496.
6. Haque, A., S. E. Best, K. Unosson, F. H. Amante, F. de Labastida, N. M. Anstey, G. Karupiah, M. J. Smyth, W. R. Heath, and C. R. Engwerda. 2011. Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria. J. Immunol. 186: 6148-6156.
7. Grau, G. E., P. F. Piguet, H. D. Engers, J. A. Louis, P. Vassalli, and P. H. Lambert. 1986. L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. J. Immunol. 137: 2348-2354.
8. Boubou, M. I., A. Collette, D. Voegtlé, D. Mazier, P. A. Cazenave, and S. Pied. 1999. T cell response in malaria pathogenesis: selective increase in T cells carrying the TCR V(beta)8 during experimental cerebral malaria. Int. Immunol. 11: 1553-1562.
9. Grau, G. E., L. F. Fajardo, P. F. Piguet, B. Allet, P. H. Lambert, and P. Vassalli. 1987. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237: 1210-1212.
10. Grau, G. E., H. Heremans, P. F. Piguet, P. Pointaire, P. H. Lambert, A. Billiau, and P. Vassalli. 1989. Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc. Natl. Acad. Sci. USA 86: 5572-5574.
11. Fauconnier, M., J. Palomo, M. L. Bourigault, S. Meme, F. Szeremeta, J. C. Beloeil, A. Danneels, S. Charron, P. Rihet, B. Ryffel, and V. F. Quesniaux. 2012. IL-12Rβ2 is essential for the development of experimental cerebral malaria. J. Immunol. 188: 1905-1914.
12. Zhu, J., and W. E. Paul. 2008. CD4 T cells: fates, functions, and faults. Blood 112: 1557-1569.
13. Lazarevic, V., and L. H. Glimcher. 2011. T-bet in disease. Nat. Immunol. 12: 597-606.
14. Paul, W. E., and J. Zhu. 2010. How are T(H)2-type immune responses initiated and amplified? Nat. Rev. Immunol. 10: 225-235.
15. Ghoreschi, K., A. Laurence, X. P. Yang, K. Hirahara, and J. J. O'Shea. 2011. T helper 17 cell heterogeneity and pathogenicity in autoimmune disease. Trends Immunol. 32: 395-401.
16. Shevach, E. M. 2009. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636-645.
17. Nie, C. Q., N. J. Bernard, L. Schofield, and D. S. Hansen. 2007. CD4+ CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis. Infect. Immun. 75: 2275-2282.
18. Amante, F. H., A. C. Stanley, L. M. Randall, Y. Zhou, A. Haque, K. McSweeney, A. P. Waters, C. J. Janse, M. F. Good, G. R. Hill, and C. R. Engwerda. 2007. A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria. Am. J. Pathol. 171: 548-559.
19. Vigário, A. M., O. Gorgette, H. C. Dujardin, T. Cruz, P. A. Cazenave, A. Six, A. Bandeira, and S. Pied. 2007. Regulatory CD4+ CD25+ Foxp3+ T cells expand during experimental Plasmodium infection but do not prevent cerebral malaria. Int. J. Parasitol. 37: 963-973.
20. Randall, L. M., F. H. Amante, K. A. McSweeney, Y. Zhou, A. C. Stanley, A. Haque, M. K. Jones, G. R. Hill, G. M. Boyle, and C. R. Engwerda. 2008. Common strategies to prevent and modulate experimental cerebral malaria in mouse strains with different susceptibilities. Infect. Immun. 76: 3312-3320.
21. Steeg, C., G. Adler, T. Sparwasser, B. Fleischer, and T. Jacobs. 2009. Limited role of CD4+Foxp3+ regulatory T cells in the control of experimental cerebral malaria. J. Immunol. 183: 7014-7022.
22. Haque, A., S. E. Best, F. H. Amante, S. Mustafah, L. Desbarrieres, F. de Labastida, T. Sparwasser, G. R. Hill, and C. R. Engwerda. 2010. CD4+ natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo. PLoS Pathog. 6: e1001221.
23. Wu, J. J., G. Chen, J. Liu, T. Wang, W. Zheng, and Y. M. Cao. 2010. Natural regulatory T cells mediate the development of cerebral malaria by modifying the pro-inflammatory response. Parasitol. Int. 59: 232-241.
24. Hansen, D. S., and L. Schofield. 2010. Natural regulatory T cells in malaria: host or parasite allies? PLoS Pathog. 6: e1000771.
25. Bettelli, E., T. Korn, M. Oukka, and V. K. Kuchroo. 2008. Induction and effector functions of T(H)17 cells. Nature 453: 1051-1057.
26. Ishida, H., C. Matsuzaki-Moriya, T. Imai, K. Yanagisawa, Y. Nojima, K. Suzue, M. Hirai, Y. Iwakura, A. Yoshimura, S. Hamano, et al. 2010. Development of experimental cerebral malaria is independent of IL-23 and IL-17. Biochem. Biophys. Res. Commun. 402: 790-795.
27. Oakley, M. S., T. F. McCutchan, V. Anantharaman, J. M. Ward, L. Faucette, C. Erexson, B. Mahajan, H. Zheng, V. Majam, L. Aravind, and S. Kumar. 2008. Host biomarkers and biological pathways that are associated with the expression of experimental cerebral malaria in mice. Infect. Immun. 76: 4518-4529.
28. Oakley, M. S., V. Majam, B. Mahajan, N. Gerald, V. Anantharaman, J. M. Ward, L. J. Faucette, T. F. McCutchan, H. Zheng, M. Terabe, et al 2009. Pathogenic roles of CD14, galectin-3, and OX40 during experimental cerebral malaria in mice. PLoS ONE 4: e6793.
29. Oakley, M. S., V. Anantharaman, T. M. Venancio, H. Zheng, B. Mahajan, V. Majam, T. F. McCutchan, T. G. Myers, L. Aravind, and S. Kumar. 2011. Molecular correlates of experimental cerebral malaria detectable in whole blood. Infect. Immun. 79: 1244-1253.
30. Kumar, S., M. F. Good, F. Dontfraid, J. M. Vinetz, and L. H. Miller. 1989. Interdependence of CD4+ T cells and malarial spleen in immunity to Plasmodium vinckei vinckei. Relevance to vaccine development. J. Immunol. 143: 2017-2023.
31. Oakley, M. S., N. Gerald, V. Anantharaman, Y. Gao, V. Majam, B. Mahajan, P. T. Pham, L. Lotspeich-Cole, T. G. Myers, T. F. McCutchan, et al 2013. Radiation-induced cellular and molecular alterations in asexual intraerythrocytic Plasmodium falciparum. J. Infect. Dis. 207: 164-174.
32. + T cells to the brain during Plasmodium berghei-mediated cerebral malaria. J. Immunol. 178: 5779-5788.
33. Ball, E. A., M. R. Sambo, M. Martins, M. J. Trovoada, C. Benchimol, J. Costa, L. Antunes Gonçalves, A. Coutinho, and C. Penha-Gonçalves. 2013. IFNAR1 controls progression to cerebral malaria in children and CD8+ T cell brain pathology in Plasmodium berghei-infected mice. J. Immunol. 190: 5118-5127.
34. Sullivan, B. M., A. Juedes, S. J. Szabo, M. von Herrath, and L. H. Glimcher. 2003. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc. Natl. Acad. Sci. USA 100: 15818-15823.
35. Szabo, S. J., S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669.
36. Amani, V., A. M. Vigário, E. Belnoue, M. Marussig, L. Fonseca, D. Mazier, and L. Rénia. 2000. Involvement of IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur. J. Immunol. 30: 1646-1655.
37. Belnoue, E., S. M. Potter, D. S. Rosa, M. Mauduit, A. C. Grüner, M. Kayibanda, A. J. Mitchell, N. H. Hunt, and L. Rénia. 2008. Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria. Parasite Immunol. 30: 544-553.
38. Villegas-Mendez, A., R. Greig, T. N. Shaw, J. B. de Souza, E. Gwyer Findlay, J. S. Stumhofer, J. C. Hafalla, D. G. Blount, C. A. Hunter, E. M. Riley, and K. N. Couper. 2012. IFN-β-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain. J. Immunol. 189: 968-979.
39. Zhu, J., D. Jankovic, A. J. Oler, G. Wei, S. Sharma, G. Hu, L. Guo, R. Yagi, H. Yamane, G. Punkosdy, et al. 2012. The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses. Immunity 37: 660-673.
40. Esensten, J. H., M. R. Lee, L. H. Glimcher, and J. A. Bluestone. 2009. T-betdeficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function. J. Immunol. 183: 75-82.
41. Miu, J., A. J. Mitchell, M. Müller, S. L. Carter, P. M. Manders, J. A. McQuillan, B. M. Saunders, H. J. Ball, B. Lu, I. L. Campbell, and N. H. Hunt. 2008. Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. J. Immunol. 180: 1217-1230.
42. Hunt, N. H., and G. E. Grau. 2003. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 24: 491-499.
43. Yañez, D. M., D. D. Manning, A. J. Cooley, W. P. Weidanz, and H. C. van der Heyde. 1996. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J. Immunol. 157: 1620-1624.
44. Szabo, S. J., B. M. Sullivan, C. Stemmann, A. R. Satoskar, B. P. Sleckman, and L. H. Glimcher. 2002. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295: 338-342.
45. Engwerda, C. R., T. L. Mynott, S. Sawhney, J. B. De Souza, Q. D. Bickle, and P. M. Kaye. 2002. Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J. Exp. Med. 195: 1371-1377.
46. Ganzalo, J. A., G. Q. Jia, V. Aguirre, D. Friend, A. J. Coyle, N. A. Jenkins, G. S. Lin, H. Katz, A. Lichtman, N. Copeland, et al 1996. Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity 4: 1-14.
47. Garcia-Zepeda, E. A., M. E. Rothenberg, R. T. Ownbey, J. Celestin, P. Leder, and A. D. Luster. 1996. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat. Med. 2: 449-456.
48. Kurtzhals, J. A., C. M. Reimert, E. Tette, S. K. Dunyo, K. A. Koram, B. D. Akanmori, F. K. Nkrumah, and L. Hviid. 1998. Increased eosinophil activity in acute Plasmodium falciparum infection - association with cerebral malaria. Clin. Exp. Immunol. 112: 303-307.
49. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277: 2005-2007.
50. Gutierrez-Ramos, J. C., C. Lloyd, and J. A. Gonzalo. 1999. Eotaxin: from an eosinophilic chemokine to a major regulator of allergic reactions. Immunol. Today 20: 500-504.
51. Demetri, G. D., and J. D. Griffin. 1991. Granulocyte colony-stimulating factor and its receptor. Blood 78: 2791-2808.
52. Waki, S., R. Kurihara, H. Nemoto, and M. Suzuki. 1993. Effect of recombinant human colony-stimulating factor on the course of parasitaemia in non-lethal rodent malaria. Parasitol. Res. 79: 703-705.
53. Wilson, N. O., T. Bythwood, W. Solomon, P. Jolly, N. Yatich, Y. Jiang, F. Shuaib, A. A. Adjei, W. Anderson, and J. K. Stiles. 2010. Elevated levels of IL-10 and G-CSF associated with asymptomatic malaria in pregnant women. Infect. Dis. Obstet. Gynecol. 2010: 2010.
54. Sloand, E. M., S. Kim, J. P. Maciejewski, F. Van Rhee, A. Chaudhuri, J. Barrett, and N. S. Young. 2000. Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood 95: 2269-2274.
55. Franzke, A., W. Piao, J. Lauber, P. Gatzlaff, C. Könecke, W. Hansen, A. SchmittThomsen, B. Hertenstein, J. Buer, and A. Ganser. 2003. G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. Blood 102: 734-739.
56. Kitabayashi, A., M. Hirokawa, Y. Hatano, M. Lee, J. Kuroki, H. Niitsu, and A. B. Miura. 1995. Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor-alpha production. Blood 86: 2220-2227.
57. Conductier, G., N. Blondeau, A. Guyon, J. L. Nahon, and C. Rovère. 2010. The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J. Neuroimmunol. 224: 93-100.
58. Dechkum, N., H. Hananantachai, J. Patarapotikul, J. Ohashi, S. Krudsood, S. Looareesuwan, and K. Tokunaga. 2006. Monocyte chemoattractant protein 1 (MCP-1) gene polymorphism is not associated with severe and cerebral malaria in Thailand. Jpn. J. Infect. Dis. 59: 239-244.
59. Hanum P, S., M. Hayano, and S. Kojima. 2003. Cytokine and chemokine responses in a cerebral malaria-susceptible or - resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain. Int. Immunol. 15: 633-640.
60. Gu, L., S. Tseng, R. M. Horner, C. Tam, M. Loda, and B. J. Rollins. 2000. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404: 407-411.
61. Nacher, M., P. Singhasivanon, B. Traore, S. Vannaphan, F. Gay, D. Chindanond, J. F. Franetich, D. Mazier, and S. Looareesuwan. 2002. Helminth infections are associated with protection from cerebral malaria and increased nitrogen derivatives concentrations in Thailand. Am. J. Trop. Med. Hyg. 66: 304-309.
62. Waknine-Grinberg, J. H., D. Gold, A. Ohayon, E. Flescher, A. Heyfets, M. J. Doenhoff, G. Schramm, H. Haas, and J. Golenser. 2010. Schistosoma mansoni infection reduces the incidence of murine cerebral malaria. Malar. J. 9: 5.